From: Boris Nikolic

From: Boris Nikolic To: Jeffrey <jeevacation@gmail.com> Subject: RE: China Date: Thu, 17 May 2012 21:59:47 +0000 What is this??? Who is David? Do not get it. B Sent from my Windows Phone From: Jeffrey Sent: Thursday, May 17, 2012 22:25 To: Boris Nikolic Subject: Fwd: China 77 Sorry for all the typos .Sent from my iPhone Begin forwarded message: From: David Stern Date: May 17, 2012 3:30:40 PM EDT To: Jeffrey Epstein leevacation@gmail.com> Subject: Fwd: China Please see below. I suggested a call with you. Weird..... Begin forwarded message: From: Richard Merkin < Subject: RE: China Date: 17 May 2012 20:25:33 GMT+01:00 To: " " gcl David, I am going to be in Palm Springs tomorrow running back and forth between two venues. One, a healthcare conference, which is Thursday, Friday, Saturday and a tennis event with Bill Gates Friday, Saturday, and Sunday, so I may be on the court in the afternoon. What I meant by structure would be either convertible preferred or a note with detachable warrants, etc., but most importantly what would secure the investment. I appreciate the benchmarks, but wouldn't each benchmark have to have a tangible worth for security purposes? And I still need clarification on source of revenue. Is there an agreement from a credible buyer to purchase once the benchmarks are met? I'm leaving in an hour for the conference and I should be back Tuesday, so either Wednesday or Thursday should be good. EFTA00935675 Begin forwarded message: From: Richard Merkin < Subject: RE: China Date: 16 May 2012 00:16:20 GMT+01:00 To: Can you send me a structure that will protect our down side. I will have our counsel, Mike Kelcy review it. He had questions about how do we monetize this, what happens after the expiration of the 5 year contractual period, how does AG capture the benefits of increased efficiency and PRC healthcare delivery system? I think I explained most of his concerns to him, but I wasn't able to specify what secures the $10M investment. Any help in clarification would be appreciated. EFTA00935676